These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1981981)

  • 1. [Roferon: present and future indications].
    Ostronoff M; Zambon E; Schlumberger M; Parmentier C; Hayat M
    Bull Cancer; 1990; 77(12):1245-9. PubMed ID: 1981981
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of interferon in the therapy of low grade lymphoma.
    McLaughlin P
    Leuk Lymphoma; 1993; 10 Suppl():17-20. PubMed ID: 8481666
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon therapy in multiple myeloma].
    Ludwig H; Scheithauer W; Kührer I; Kuzmits R; Gisslinger G; Linkesch W; Zielinski C; Fritz E
    Onkologie; 1988 Aug; 11(4):192-6. PubMed ID: 3054670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roferon-A in solid tumor therapy.
    Semin Oncol; 1989 Feb; 16(1 Suppl 1):1-50. PubMed ID: 2919287
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternating recombinant and natural alpha-interferon helps to prevent clinical resistance to interferon in cutaneous T-cell lymphoma treatment.
    Altomare G; Capella GL; Frigerio E
    Acta Derm Venereol; 1998 Mar; 78(2):159. PubMed ID: 9534907
    [No Abstract]   [Full Text] [Related]  

  • 6. [Roferon--a simplified interferon].
    Soins; 2001 Feb; (652):17. PubMed ID: 12008439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Roferon-A (interferon alfa-2a) permitted for AIDS-associated Kaposi's sarcoma by the BGA].
    Immun Infekt; 1989 Feb; 17(1):VIII. PubMed ID: 2925218
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interferon: IntronA, Roferon].
    Gaudy-Marqueste C; Grob JJ
    Ann Dermatol Venereol; 2007 Dec; 134(12):917-21. PubMed ID: 18166911
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of alpha interferon in the biomodulation of disease: preface.
    Wadler S
    Med Oncol; 1995 Mar; 12(1):1-2. PubMed ID: 8542241
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].
    Lopez Bran E; Aguilar R; Marron JA; Figueredo MA; Garcia Ruiz JM
    Med Cutan Ibero Lat Am; 1989; 17(4):269-73. PubMed ID: 2693866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
    Guilhot F; Dreyfus B; Desmarest MC; Giraud C; Huret JL; Brizard A; Tanzer J
    Nouv Rev Fr Hematol (1978); 1989; 31(2):171-3. PubMed ID: 2771633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma.
    Tourani JM; Leaute JB; Lessana-Leibowitch M; Andrieu JM
    Nouv Rev Fr Hematol (1978); 1989; 31(4):315-6. PubMed ID: 2691984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferons in the management of multiple myeloma.
    Cooper MR
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):21-5. PubMed ID: 3057642
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of interferon-alfa (reaferon) in patients with chronic myeloleukemia].
    Machiulaĭtene ER; Lasunskaia EB; Nefedova IuB; Perekalina TA; Salogub GN; Poliakova LE
    Ter Arkh; 1996; 68(10):44-7. PubMed ID: 9026942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of alpha interferon preparations in acute lymphoblastic leukemia in children during remission].
    Gavrilova IE; Kuznetsov IP; Denisov LA; Maiakova SA; Orlova TG; Kadagidze ZG; Makhonova LA
    Pediatriia; 1991; (11):75-8. PubMed ID: 1766748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of interferon-alpha in solid tumours: part 1.
    Decatris M; Santhanam S; O'Byrne K
    BioDrugs; 2002; 16(4):261-81. PubMed ID: 12196039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alpha-interferon in present-day treatment of myeloma].
    Demina EA; Votiakova OM
    Gematol Transfuziol; 1996; 41(2):32-6. PubMed ID: 8754159
    [No Abstract]   [Full Text] [Related]  

  • 18. Roferon-A in combination with Tigason in cutaneous T-cell lymphomas.
    Dreno B; Celerier P; Litoux P
    Acta Haematol; 1993; 89 Suppl 1():28-32. PubMed ID: 8475670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whither interferon for myeloma and other hematologic malignancies?
    Alexanian R; Weber D
    Ann Intern Med; 1996 Jan; 124(2):264-5. PubMed ID: 8534004
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alpha-2a-interferon (Reaferon) in the treatment of patients with multiple myeloma].
    Bessmel'tsev SS; Abdulkadyrov KM
    Vopr Onkol; 1999; 45(4):393-7. PubMed ID: 10532098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.